Related Experiment Videos
Urinary excretion of glomerular basement membrane-related peptides in children with renal disorders
A M Wingen1, K Schärer, E W Rauterberg
1Institute of Immunology, University of Heidelberg, Federal Republic of Germany.
Insights
Researchers analyzed glomerular basement membrane (GBM)-related peptides in urine from renal disease patients. Specific peptide excretion patterns were observed, particularly concerning glomerular filtration rate (GFR), but were not disease-specific.
Area of Science:
- Nephrology
- Biochemistry
- Immunology
Background:
- The glomerular basement membrane (GBM) is crucial for kidney filtration.
- Understanding GBM peptide excretion can offer insights into renal health.
- Previous studies have not fully characterized urinary GBM peptides in various renal diseases.
Purpose of the Study:
- To analyze urinary excretion of glomerular basement membrane (GBM)-related peptides in patients with diverse renal diseases.
- To investigate the relationship between peptide excretion patterns and glomerular filtration rate (GFR).
- To determine if urinary GBM peptide profiles are specific to particular renal conditions.
Main Methods:
- Immunoblotting was used to analyze GBM-related peptides in urine from 72 renal disease patients.
- Polyclonal antibodies against collagenase and pepsin digests of human GBM were employed.
- Antibody specificity was confirmed through antibody elution and reactivity tests; mouse immunization models were also used.
Main Results:
- Excretion of GBM-related peptides (33, 50, 80, and 150 kD) was detected in most patients.
- Patients with reduced GFR showed higher excretion of the 33 kD peptide and no excretion of the 80 kD peptide compared to those with normal GFR.
- The observed urinary GBM peptide patterns were not specific to individual renal diseases, including Alport's syndrome.
Conclusions:
- Urinary excretion of specific GBM-related peptides varies with glomerular filtration rate.
- The analyzed GBM peptide profiles lack specificity for diagnosing particular renal diseases.
- Further research may elucidate the diagnostic potential of specific GBM peptide fragments in kidney disease.
Abstract:
Urinary excretion of glomerular basement membrane (GBM)-related peptides was analysed in 72 patients with a variety of renal diseases by immunoblotting using polyclonal antibodies against either collagenase or pepsin digests of human GBM. The specificity of the antibodies was verified by elution of antibodies bound to urinary GBM-related peptides on nitrocellulose blots and demonstration of reactivity of the eluted antibodies with the respective GBM digests. Furthermore, six mice immunized with urinary GBM-related peptides all developed focal linear deposits of mouse IgG along their GBM, linear and mesangial deposits of C3 in the glomeruli and serum antibodies reactive with human GBM. Monoclonal antibodies against urinary GBM-related peptides of one of the mice reacted with different peptides of the non-collagenous and collagenous domains of type IV collagen, the major structural protein of GBM. In the majority of the 75 patients' urines tested, excretion of GBM-related peptides with molecular weights of 33, 50, 80 and 150 kilodaltons (kD) was detectable. Patients with a diminished glomerular filtration rate (GFR) demonstrated excretion of the 33 kD peptide more frequently (91%) and never of the 80 kD peptide as compared with patients with normal GFR (33 kD [42%] 80 kD [87%]). The pattern of urinary GBM-related peptides was not specific for the underlying renal disease as in Alport's syndrome.